Development of a proteomic signature associated with severe disease for patients with COVID-19 using...
Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies
About this item
Full title
Author / Creator
Castro-Pearson, Sandra , Samorodnitsky, Sarah , Yang, Kaifeng , Lotfi-Emran, Sahar , Ingraham, Nicholas E. , Bramante, Carolyn , Jones, Emma K. , Greising, Sarah , Yu, Meng , Steffen, Brian T. , Svensson, Julia , Åhlberg, Eric , Österberg, Björn , Wacker, David , Guan, Weihua , Puskarich, Michael , Smed-Sörensen, Anna , Lusczek, Elizabeth , Safo, Sandra E. and Tignanelli, Christopher J.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Significant progress has been made in preventing severe COVID-19 disease through the development of vaccines. However, we still lack a validated baseline predictive biologic signature for the development of more severe disease in both outpatients and inpatients infected with SARS-CoV-2. The objective of this study was to develop and externally vali...
Alternative Titles
Full title
Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies
Authors, Artists and Contributors
Author / Creator
Samorodnitsky, Sarah
Yang, Kaifeng
Lotfi-Emran, Sahar
Ingraham, Nicholas E.
Bramante, Carolyn
Jones, Emma K.
Greising, Sarah
Yu, Meng
Steffen, Brian T.
Svensson, Julia
Åhlberg, Eric
Österberg, Björn
Wacker, David
Guan, Weihua
Puskarich, Michael
Smed-Sörensen, Anna
Lusczek, Elizabeth
Safo, Sandra E.
Tignanelli, Christopher J.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8c6ba0735d984f7a80f031a5f8cacf53
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c6ba0735d984f7a80f031a5f8cacf53
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-46343-1
